Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.61 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.61 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.61 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.61 |
| ▸ | PLAU | P00749 | 2/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.55 |
| ▸ | SYK | P43405 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | PFKFB4 | Q16877 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2119745 | 0.97 | FFAR4 (0.64) | FFAR4GABRG2GABRB3GABRA3PLAU | |
| SCHEMBL2117837 | 0.87 | STAT3 (0.60) | FFAR4GABRG2GABRB3GABRA3PLAU | |
| SCHEMBL30434229 | 0.84 | GAA (0.76) | FFAR4GABRG2GABRB3GABRA3CYP19A1 | |
| SCHEMBL806437 | 0.84 | GAA (0.76) | FFAR4GABRG2GABRB3GABRA3CYP19A1 | |
| SCHEMBL7564170 | 0.84 | GAA (0.76) | FFAR4GABRG2GABRB3GABRA3CYP19A1 | |
| SCHEMBL2118247 | 0.83 | ALPL (0.54) | FFAR4GABRG2GABRB3GABRA3PLAU | |
| SCHEMBL2118375 | 0.83 | ALPL (0.54) | FFAR4GABRG2GABRB3GABRA3PLAU | |
| SCHEMBL2117670 | 0.83 | MAPT (0.53) | FFAR4GABRG2GABRB3GABRA3PLAU | |
| SCHEMBL2118551 | 0.82 | PIK3CB (0.50) | FFAR4GABRG2GABRB3GABRA3CYP19A1 | |
| SCHEMBL2119862 | 0.82 | FFAR4 (0.53) | FFAR4GABRG2GABRB3GABRA3PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120095024-A1 | TOLUIDINE SULFONAMIDES AND THEIR USE | ELARA PHARMACEUTICALS GMBH (DE) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095024-A1 | TOLUIDINE SULFONAMIDES AND THEIR USE | HIF1AN, HIF1A, EGLN2 | FFAR4 4059/4885GABRG2 4604/4885GABRB3 4684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.